Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Global Health Ltd.
Change Company   
BSE Code 543654
ISIN Demat INE474Q01031
Book Value 130.14
NSE Code MEDANTA
Dividend Yield % 0.04
Market Cap 308172.12
P/E 66.77
EPS 17.17
Face Value 2  
19-Jun-2025 Global Health informs about analyst meet
13-Jun-2025 Global Health informs about analyst meet
03-Jun-2025 Global Health informs about analyst meet
27-May-2025 Global Health informs about analyst meet
15-May-2025 Global Health informs about allotment of equity s...
15-May-2025 Global Health informs about allotment under ESOP
15-May-2025 Global Health informs about meeting updates
15-May-2025 Global Health informs about outcome of board meet...
05-May-2025 Global Health informs about board meeting
28-Apr-2025 Global Health gets board’s nod to purchase land p...
08-Apr-2025 Global Health gets offer from AEGCL to acquire la...
08-Apr-2025 Global Health soars on getting offer from AEGCL t...
01-Mar-2025 Global Health informs about analyst meet
01-Mar-2025 Global Health informs about disclosure
20-Feb-2025 Global Health informs about disclosure
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.